Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. As a result, access to the trial information and related links is removed from the page.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe page shows revision v3.6.6, replacing v3.6.5. This indicates an update to the site's version or content rather than changes to the study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page version was updated from v3.6.4 to v3.6.5, reflecting a new release of the page template. No study data or eligibility criteria are altered.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor page/template update. No study data or eligibility details are changed.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now displays revision v3.6.3, updating from the previous v3.6.2 and signaling a refreshed publish of the study details.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page displays a newer revision number (v3.6.2) replacing the previous one (v3.6.0), indicating an update to the page's version metadata.SummaryDifference0.0%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.